These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3524123)

  • 21. Single photon emission tomography in growth-hormone related Creutzfeldt-Jakob disease.
    Markus HS; Harrison MJ; Costa DC
    Lancet; 1991 Sep; 338(8767):630-1. PubMed ID: 1679165
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pituitary dwarfism--progress of therapy].
    Suwa S
    Nihon Rinsho; 1986 Mar; 44(3):703-10. PubMed ID: 3090312
    [No Abstract]   [Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
    Masson C; Delalande I; Deslys JP; Hénin D; Fallet-Bianco C; Dormont D; Leys D
    Neurology; 1994 Jan; 44(1):179-80. PubMed ID: 7904734
    [No Abstract]   [Full Text] [Related]  

  • 24. Transmission of Creutzfeldt-Jakob disease by investigative and therapeutic procedures.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(2):89-98. PubMed ID: 1932464
    [No Abstract]   [Full Text] [Related]  

  • 25. Leads from the MMWR. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.
    JAMA; 1985 Jul; 254(4):475, 479. PubMed ID: 3892063
    [No Abstract]   [Full Text] [Related]  

  • 26. The human growth hormone Creutzfeld Jakob disease litigation.
    Owen R
    Med Leg J; 1997; 65 ( Pt 2)():46-64. PubMed ID: 9241994
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of children with short stature with human growth hormone and its potential risks].
    Sizonenko PC
    Arch Fr Pediatr; 1993 May; 50(5):369-74. PubMed ID: 8239885
    [No Abstract]   [Full Text] [Related]  

  • 28. [Creutzfeldt-Jakob disease].
    Servir; 1992; 40(2):86. PubMed ID: 1585192
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth hormone use by body builders.
    Davies JS; Morgan CL; Currie CJ; Green JT
    Br J Sports Med; 1997 Dec; 31(4):352-3. PubMed ID: 9429020
    [No Abstract]   [Full Text] [Related]  

  • 30. [Creutzfeldt-Jakob disease after treatment with growth hormone: the point in July, 1998].
    Brandel JP; Agid Y
    Rev Neurol (Paris); 1998 Oct; 154(10):654-5. PubMed ID: 9846335
    [No Abstract]   [Full Text] [Related]  

  • 31. Creutzfeldt-Jakob verdict may prompt new claims.
    Carr K
    Nature; 1993 Nov; 366(6451):98. PubMed ID: 8232564
    [No Abstract]   [Full Text] [Related]  

  • 32. Problems with growth hormone.
    Med Lett Drugs Ther; 1985 Jul; 27(691):57-8. PubMed ID: 3892258
    [No Abstract]   [Full Text] [Related]  

  • 33. Status report on the US human growth hormone recipient follow-up study.
    Mills JL; Fradkin J; Schonberger L; Gunn W; Thomson RA; Piper J; Wysowski D; Brown P
    Horm Res; 1990; 33(2-4):116-9; discussion 120. PubMed ID: 2210615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Slow-virus encephalitis in subjects treated with growth hormone extract: unexpected risks of substitute therapy].
    Butturini L
    G Clin Med; 1986 Feb; 67(1):53. PubMed ID: 3539686
    [No Abstract]   [Full Text] [Related]  

  • 35. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment.
    Hintz RL
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2298-301. PubMed ID: 7629222
    [No Abstract]   [Full Text] [Related]  

  • 36. Human growth hormone distribution discontinued.
    FDA Drug Bull; 1985 Aug; 15(2):17-8. PubMed ID: 3902547
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of growth hormone free from contamination with unconventional slow viruses.
    Taylor DM; Dickinson AG; Fraser H; Robertson PA; Salacinski PR; Lowry PJ
    Lancet; 1985 Aug; 2(8449):260-2. PubMed ID: 2862429
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is there a causative relation between infectious degenerative encephalopathy and the use of growth hormone?].
    Romer TE
    Pediatr Pol; 1986 Nov; 61(11):740-4. PubMed ID: 3295737
    [No Abstract]   [Full Text] [Related]  

  • 39. Malpractice denied.
    Dickson D
    Nature; 1993 Jul; 364(6436):372. PubMed ID: 8332199
    [No Abstract]   [Full Text] [Related]  

  • 40. Human growth hormone treatment and Creutzfeldt-Jakob disease.
    Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F
    J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.